Molecular mechanisms of autosomal recessive hypercholesterolemia

Current Opinion in Lipidology

Volumn 14, Issue 2, 2003, Pages 121-127

  Cohen, Jonathan C ^a,b   Kimmel, Marek ^c   Polanski, Andrzej ^c   Hobbs, Helen H ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Rice University   (United States)

Author keywords

Adaptor protein; Clathrin box; Endocytosis; Low density lipoprotein receptor; Phosphotyrosine binding domain

Indexed keywords

ADAPTOR PROTEIN; ARGININE; ARH PROTEIN; CLATHRIN; HLA A ANTIGEN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHOTYROSINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AUTOSOMAL RECESSIVE DISORDER; CLINICAL PATHWAY; CORONARY ARTERY DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; FRAMESHIFT MUTATION; GENE IDENTIFICATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTERNALIZATION; LIPOPROTEIN BLOOD LEVEL; MISSENSE MUTATION; MOLECULAR GENETICS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; XANTHOMATOSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; AMINO ACID SEQUENCE; ANIMALS; GENES, RECESSIVE; GENETICS, POPULATION; HUMANS; HYPERCHOLESTEROLEMIA; MOLECULAR SEQUENCE DATA; RECEPTORS, LDL;

EID: 0242416622     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200304000-00002     Document Type: Review

References (33)

1. Khachadurian AK, Uthman SM. Experiences with the homozygous cases of familial hypercholesterolemia: a report of 52 patients. Nutr Metab 1973; 15:132-140.
2. Zuliani G, Arca M, Signore A, et al. Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia. Arterioscler Thromb Vasc Biol 1999; 19:802-809.
3. Zuliani G, Vigna GB, Corsini A, et al. Severe hypercholesterolaemia: unusual inheritance in an Italian pedigree. Eur J Clin Invest 1995; 25:322-331.
4. Harada-Shiba M, Tajima S, Yokoyama S, et al. Siblings with normal LDL receptor activity and severe hypercholesterolemia. Arterioscler Thromb 12; 1071-1078.
5. Schmidt HH, Stuhrmann M, Shamburek R, et al. Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia. J Clin Endocrinol Metab 1998; 83:2167-2174.
6. Goldstein J, Hobbs H, Brown M. Familial hypercholesterolemia. In: Valle D, editor, The metabolic and molecular bases of inherited disease. 8th ed., vol. II. New York: McGraw-Hill; 2001. pp. 2863-2913.
7. Norman D, Sun XM, Bourbon M, et al. Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia. J Clin Invest 1999; 104:619-628.
8. Eden E, Naoumova R, Burden J, et al. Use of homozygosity mapping to identify a region on chromosome 1 bearing a defective gene that causes autosomal recessive homozygous hypercholesterolemia in two unrelated families. Am J Hum Genet 2001; 68:653-660.
9. Garcia CK, Wilund K, Arca M, et al. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 2001; 292:1394-1398.
10. Wilund KR, Yi M, Campagna F, et al. Molecular mechanisms of autosomal recessive hypercholesterolemia. Hum Mol Genet 2002; 11:3019-3030.
11. Al-Kateb H, Bahring S, Hoffmann K, et al. Mutation in the ARH gene and a chromosome 13q locus influence cholesterol levels in a new form of digenic-recessive familial hypercholesterolemia. Circ Res 2002; 90:951-958.
12. Shen L, Wu LC, Sanlioglu S, et al. Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region: molecular cloning, exon-intron structure, composite retroposon, and breakpoint of gene duplication. J Biol Chem 1994; 269:8466-8476.
13. Frisehmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 1999; 8:1893-1900.
14. Watanabe Y, Magor KE, Parham P. Exon 5 encoding the transmembrane region of HLA-A contains a transitional region for the induction of nonsense-mediated mRNA decay. J Immunol 2001; 167:6901-6911.
15. Zhang J, Maquat LE. Evidence that translation reinitiation abrogates nonsense-mediated mRNA decay in mammalian cells. EMBO J 1997; 16:826-833.
16. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 1986; 44:283-292.
17. Arca M, Zuliani G, Wilund K, et al. Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis. Lancet 2002; 359:841-847.
18. Serre JL, Simon-Bouy B, Mornet E, et al. Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in populations genetics. Hum Genet 1990; 84:449-454.
19. Slatkin M, Rannala B. Estimating allele age. Annu Rev Genomics Hum Genet 2000; 1:225-249.
20. Zlotogora J. ARH mutations and hypercholesterolaemia in Sardinia. Lancet 2002; 360:1024.
21. Linton MF, Babaev VR, Cleaves LA, Fazio S. A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation. J Biol Chem 1999; 274:19204-19210.
22. Raal FJ, Pappu AS, Illingworth DR, et al. Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia. Atherosclerosis 2000; 150:421-428.
23. Eilheimer DW, Grundy SM, Brown MS, Goldstein JL. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc Natl Acad Sci U S A 1983; 80:4124-4128.
24. He G, Gupta S, Michaely P, et al. ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin and AP-2. J Biol Chem 2002; 277:44044-44049.
25. Dell'Angelica EC. Clathrin-binding proteins: got a motif? Join the network! Trends Cell Biol 2001; 11:315-318.
26. Forman-Kay JD, Pawson T. Diversity in protein recognition by PTB domains. Curr Opin Struct Biol 1999; 9:690-695.
27. Krchhausen T. Clathrin. Annu Rev Biochem 2000; 69:699-727.
28. ter Haar E, Harrison SC, Kirchhausen T. Peptide-in-groove interactions link target proteins to the beta-propeller of clathrin. Proc Natl Acad Sci U S A 2000; 97:1096-1100.
29. Laporte SA, Miller WE, Kim KM, Caron MG. beta-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a beta-arrestin binging site in beta 2-adaptin. J Biol Chem 2002; 277:9247-9254.
30. Davis CG, Lehrman MA, Russell DW, et al. The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors. Cell 1986; 45:15-24.
31. Havel RJ, Hamilton RL. Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism. Hepatology 1988; 8:1689-1704.
32. Pathak RK, Yokode M, Hammer RE, et al. Tissue-specific sorting of the human LDL receptor in polarized epithelia of transgenic mice. J Cell Biol 1990; 111:347-359.
33. Eden ER, Patel DD, Sun XM, et al. Restoration of LDL receptor function in cells from patients with autosomal recessive hypercholesterolemia by retroviral expression of ARH1. J Clin Invest 2002; 110(11):1695-1702.